Cannabinoid receptor type 2 expression in mouse brain: from mapping to regulation in microglia under inflammatory conditions
Preprint
Abstract
Since its detection in the brain, the cannabinoid receptor type 2 (CB2) has been deemed a promising therapeutic target for various neurological and psychiatric disorders. However, precise brain mapping of CB2 expression is currently lacking. Using magnetic cell sorting, calibrated reverse transcription-quantitative PCR, and single-nucleus RNA-seq, we revealed the low level of CB2 expression in all brain regions examined, mainly by a few microglial cells and by neurons in an even lower proportion. Upon lipopolysaccharide stimulation to simulate non-sterile neuroinflammatory conditions, we demonstrated that the inflammatory response was associated with a transient reduction in CB2 mRNA levels in the brain tissue, particularly in microglia. This result, confirmed in the BV2 microglial cells, contrasts with the positive correlation observed between CB2 mRNA levels and the inflammatory response upon stimulation by interferon-gamma, which models sterile inflammatory conditions. Thus, discrete brain CB2 expression may be upregulated or downregulated depending on the inflammatory context.Keywords
This publication has 46 references indexed in Scilit:
- Synthetic cannabinoids reduce the inflammatory activity of microglia and subsequently improve neuronal survival in vitroBrain, Behavior, and Immunity, 2022
- Dissecting functional phenotypes of microglia and macrophages in the rat brain after transient cerebral ischemiaGlia, 2018
- Selective activation of cannabinoid receptor-2 reduces neuroinflammation after traumatic brain injury via alternative macrophage polarizationBrain, Behavior, and Immunity, 2018
- Distinguishing features of microglia- and monocyte-derived macrophages after strokeActa Neuropathologica, 2017
- The CB2 receptor and its role as a regulator of inflammationCellular and Molecular Life Sciences, 2016
- Differential upregulation of the cannabinoid CB2 receptor in neurotoxic and inflammation-driven rat models of Parkinson's diseaseExperimental Neurology, 2015
- LPS/TLR4 signal transduction pathwayCytokine, 2008
- Unexpected expression of orexin-B in basal conditions and increased levels in the adult rat hippocampus during pilocarpine-induced epileptogenesisBrain Research, 2006
- Signal integration between IFNγ and TLR signalling pathways in macrophagesImmunobiology, 2006
- Cannabinoid Receptors CB1 and CB2: A Characterization of Expression and Adenylate Cyclase Modulation within the Immune SystemToxicology and Applied Pharmacology, 1997